Helen Rees

Publications

321

Citations

17.7K

h-index

70

Publishing journals

122

Years of publications

20+

Active since

2007

References

8.2K

Institutions

20

1. Assessing the physical health of service users with severe mental illness
   Mental Health Practice, Volume 28, Issue 2, Pages 35-42, Year 2025
2. Protecting mother and baby: Learnings from an Ebola vaccination campaign on the evolving landscape of vaccines and pregnancy
   PLoS Medicine, Volume 22, Issue 2, Pages e1004530-e1004530, Year 2025
3. Vaccines to prevent bacterial sexually transmitted infections: Promise, progress, and public health potential.
   PLoS medicine, Volume 22, Issue 12, Page e1004849, Year 2025
4. Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
   UNC Libraries, Year 2025
5. Clot twist – D-dimer analysis of healthy adults receiving heterologous or homologous booster COVID-19 vaccine after a single prime dose of Ad26.COV2.S in a phase II randomised open-label trial, BaSiS
   South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, Volume 115, Issue 8, Page e3121, Year 2025
6. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
   The Lancet Child & Adolescent Health, Volume 8, Issue 3, Pages 190-200, Year 2024
7. The Global Demand and Supply Balance of the Human Papillomavirus Vaccine: Implications for the Global Strategy for the Elimination of Cervical Cancer
   Vaccines, Volume 12, Issue 1, No. 4, Page 4, Year 2024
8. Safety and immunogenicity of booster vaccination and fractional dosing with Ad26. COV2.S or BNT162b2 in Ad26.COV2.Svaccinated participants
   PLOS Global Public Health, Volume 4, Issue 4, No. e0002703, Page e0002703, Year 2024
9. Interventions aimed at preventing suicide in the healthcare workforce: a systematic review
   Nursing Management, Volume 32, Issue 1, Pages 19-25, Year 2024
10. Impact of single-dose HPV vaccination on HPV 16 and 18 prevalence in South African adolescent girls with and without HIV
    Journal of the National Cancer Institute - Monographs, Volume 2024, Issue 67, Pages 337-345, Year 2024
11. High prevalence of human papillomavirus (HPV) in unvaccinated adolescent girls in South Africa, particularly those living with HIV
    Vaccine, Volume 42, Issue 26, No. 126442, Page 126442, Year 2024
12. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
    The Lancet, Volume 401, Issue 10387, Pages 1499-1507, Year 2023
13. Increasing global temperatures threaten gains in maternal and newborn health in Africa: A review of impacts and an adaptation framework
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, Volume 160, Issue 2, Pages 421-429, Year 2023
14. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs
    Vaccines, Volume 11, Issue 3, No. 690, Pages 690-690, Year 2023
15. Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule
    JNCI: Journal of the National Cancer Institute, Volume 115, Issue 3, Pages 246-249, Year 2023
16. Hepatitis E vaccine—Illuminating the barriers to use
    PLoS Neglected Tropical Diseases, Volume 17, Issue 1, No. e0010969, Page e0010969, Year 2023
17. Impact and cost‐effectiveness of the national scale‐up of HIV pre‐exposure prophylaxis among female sex workers in South Africa: a modelling analysis
    Journal of the International AIDS Society, Volume 26, Issue 2, No. e26063, Pages e26063-e26063, Year 2023
18. No woman left behind: achieving cervical cancer elimination among women living with HIV
    The Lancet HIV, Volume 10, Issue 6, Pages e412-e420, Year 2023
19. Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
    Journal of the International AIDS Society, Volume 26, Issue 6, No. e26118, Year 2023
20. State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop
    Preventive Medicine Reports, Volume 35, No. 102331, Page 102331, Year 2023

No publications in the index yet.